✦ LIBER ✦

Frequency and clinical outcomes of flares related to nucleos(t)ide analogue therapy in patients with chronic hepatitis B

✍ Scribed by N.-P. Zhang; J. G. P. Reijnders; M. Perquin; B. E. Hansen; H. L. A. Janssen

Book ID: 108886591
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 73 KB
Volume: 18
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2011.01448.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcomes after nucleos(t)ide a

Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative

✍ He, Dengming; Guo, Shimin; Chen, Wen; Chen, Xianli; Yan, Guohua; Wang, Jie; Li, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 253 KB

Effect of nucleos(t)ide analogue therapy

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis

✍ Kumada, Takashi; Toyoda, Hidenori; Tada, Toshifumi; Kiriyama, Seiki; Tanikawa, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 954 KB

Virological breakthrough and resistance

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

✍ Chanunta Hongthanakorn; Watcharasak Chotiyaputta; Kelly Oberhelman; Robert J. Fo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Virological breakthrough and resistance

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

✍ Ezequiel Ridruejo; Raúl Adrover; Marcelo O. Silva 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

We read with great interest the article by Teixera-Clerc et al., 1 regarding the hepatoprotective properties displayed by cannabinoid receptor 2 (CB2) agonists in a mouse model of carbon tetrachloride (CCl 4 )-induced liver injury. Acute hepatitis induced by CCl 4 was accelerated in CB2 knockout mic

Adherence to nucleos(t)ide analogues for

Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs

✍ W. Chotiyaputta; C. Hongthanakorn; K. Oberhelman; R. J. Fontana; T. Licari; A. S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

632 Discrepancy Between Virological Brea

632 Discrepancy Between Virological Breakthrough and Confirmed Genotypic Resistance in Chronic Hepatitis B Patients Receiving Nucleos(T)Ide Analogue Therapy in Clinical Practice

✍ Hongthanakorn, Chanunta; Chotiyaputta, Watcharasak; Oberhelman, Kelly; Fontana, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 106 KB